Reynie Purnama Raya

Ms. Reynie Purnama Raya

Institute for Global Health, University College London
+1

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
TOTope Oyelade
Tope Oyelade
JAJaber S. Alqahtani
Jaber S. Alqahtani
AHAhmed Hjazi
Ahmed Hjazi
ALAmy Li
Amy Li
AKAmi Kamila
Ami Kamila
RRReynie Purnama Raya
Reynie Purnama Raya
Background: The relationship between HIV (human immunodeficiency virus) and COVID-19 clinical outcome is uncertain, with conflicting data and hypotheses. We aimed to assess the prevalence of people living with HIV (PLWH) among COVID-19 cases and whether HIV infection affects the risk of severe COVID-19 or related death at the global and continental level. Methods: Electronic databases were systematically searched in July 2021. In total, 966 studies were screened following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Narratives were synthesised and data pooled for the global and continental prevalence of HIV–SARS-CoV-2 coinfection. The relative risks of severity and mortality in HIV-infected COVID-19 patients were computed using a random-effect model. Risk of bias was assessed using the Newcastle–Ottawa score and Egger’s test, and presented as funnel plots. Results: In total, 43 studies were included involving 692,032 COVID-19 cases, of whom 9097 (1.3%) were PLWH. The global prevalence of PLWH among COVID-19 cases was 2% (95% CI = 1.7–2.3%), with the highest prevalence observed in sub-Saharan Africa. The relative risk (RR) of severe COVID-19 in PLWH was significant only in Africa (RR = 1.14, 95% CI = 1.05–1.24), while the relative risk of mortality was 1.5 (95% CI = 1.45–2.03) globally. The calculated global risk showed that HIV infection may be linked with increased COVID-19 death. The between-study heterogeneity was significantly high, while the risk of publication bias was not significant. Conclusions: Although there is a low prevalence of PLWH among COVID-19 cases, HIV infection may increase the severity of COVID-19 in Africa and increase the risk of death globally.

Jaber AlqahtaniJaber Alqahtani
Jaber Alqahtani
AAAbdulelah Mastour Aldhahir
Abdulelah Mastour Aldhahir
SGShouq Saleh Al Ghamdi
Shouq Saleh Al Ghamdi
SASalma AlBahrani
Salma AlBahrani
IAIbrahim A. AlDraiwiesh
Ibrahim A. AlDraiwiesh
TOTope Oyelade
Tope Oyelade
Background: Severe COVID-19 is associated with hypoxemia and acute respiratory distress syndrome (ARDS), which may predispose multiorgan failure and death. Inhaled nitric oxide (iNO) is a clinical vasodilator used in the management of acute respiratory distress syndrome (ARDS). This study evaluated the response rate to iNO in patients with COVID-19-ARDS. Method: We searched Medline and Embase databases in May 2022, and data on the use of iNO in the treatment of ARDS in COVID-19 patients were synthesized from studies that satisfied predefined inclusion criteria. A systematic synthesis of data was performed followed by meta-analysis. We performed the funnel plot and leave-one-out sensitivity test on the included studies to assess publication bias and possible exaggerated effect size. We compared the effect size of the studies from the Unites States with those from other countries and performed meta-regression to assess the effect of age, year of publication, and concomitant vasodilator use on the effect size. Results: A total of 17 studies (including 712 COVID-19 patients) were included in this systematic review of which 8 studies (involving 265 COVID-19 patients) were subjected to meta-analysis. The overall response rate was 66% (95% CI, 47–84%) with significantly high between-studies heterogeneity (I2 = 94%, p < 0.001). The funnel plot showed publication bias, although the sensitivity test using leave-one-out analysis showed that removing any of the study does not remove the significance of the result. The response rate was higher in the Unites States, and meta-regression showed that age, year of publication, and use of concomitant vasodilators did not influence the response rate to iNO. Conclusion: iNO therapy is valuable in the treatment of hypoxemia in COVID-19 patients and may improve systemic oxygenation in patients with COVID-19-ARDS. Future studies should investigate the mechanism of the activity of iNO in COVID-19 patients to provide insight into the unexplored potential of iNO in general ARDS.

11 August 2023 in Heliyon
Verified
Journal Article
Open access
Jaber AlqahtaniJaber Alqahtani
Jaber Alqahtani
RMRenata G. Mendes
Renata G. Mendes
MTMaria Isabel Triches
Maria Isabel Triches
TSTatiana de Oliveira Sato
Tatiana de Oliveira Sato
JITHIN K SREEDHARANJITHIN K SREEDHARAN
JITHIN K SREEDHARAN
TOTope Oyelade
Tope Oyelade
The result of the movement restrictions during the COVID-19 pandemic was an impromptu and abrupt switch from in-person to online teaching. Most focus has been on the perception and experience of students during the process. The aim of this international survey is to assess staffs' perspectives and challenges of online teaching during the COVID-19 lockdown. Cross-sectional research using a validated online survey was carried out in seven countries (Brazil, Saudi Arabia, Jordan, Indonesia, India, the United Kingdom, and Egypt) between the months of December 2021 and August 2022, to explore the status of online teaching among faculty members during the COVID-19 pandemic. Variables and response are presented as percentages while logistic regression was used to assess the factors that predict levels of satisfaction and the challenges associated with online instruction. A total of 721 response were received from mainly male (53%) staffs. Most respondents are from Brazil (59%), hold a Doctorate degree (70%) and have over 10 years of working experience (62%). Although, 67% and 79% have relevant tools and received training for online teaching respectively, 44% report that online teaching required more preparation time than face-to-face. Although 41% of respondents were uncertain about the outcome of online teaching, 49% were satisfied with the process. Also, poor internet bandwidth (51%), inability to track students' engagement (18%) and Lack of technical skills (11.5%) were the three main observed limitations. Having little or no prior experience of online teaching before the COVID-19 pandemic [OR, 1.58 (95% CI, 1.35–1.85)], and not supporting the move to online teaching mode [OR, 0.56 (95% CI,0.48–0.64)] were two main factors independently linked with dissatisfaction with online teaching. While staffs who support the move to online teaching were twice likely to report no barriers [OR, 2.15 (95% CI, 1.61–2.86)]. Although, relevant tools and training were provided to support the move to online teaching during COVID-19 lockdown, barriers such as poor internet bandwidth, inability to track students’ engagement and lack of technical skills were main limitations observed internationally by teaching staffs. Addressing these barriers should be the focus of higher education institution in preparation for future disruptions to traditional teaching modes.

29 September 2022 in HIV Medicine
Verified
Journal Article
Open access
RRReynie Purnama Raya
Reynie Purnama Raya
HCHilary Curtis
Hilary Curtis
RKRanjababu Kulasegaram
Ranjababu Kulasegaram
GCGraham S. Cooke
Graham S. Cooke
FBFiona Burns
Fiona Burns
TSthe BHIVA Audit and Standards Sub‐committee
the BHIVA Audit and Standards Sub‐committee
Objectives: We aimed to describe clinical policies for the management of people with HIV/hepatitis C virus (HCV) coinfection and to audit routine monitoring and assessment of people with HIV/HCV coinfection attending UK HIV care.Methods: This was a clinic survey and retrospective case‐note review. HIV clinics in the UK participated in the audit from May to July 2021 by completing an online questionnaire regarding their clinic's policies for the management of people with HIV/HCV coinfection, and by contributing to a case‐note review of people living with HIV with detectable HCV RNA who were under the care of their service.Results: Ninety‐five clinics participated in the clinic survey; of these, 15 (15.8%) were regional specialist centres, 19 (20.0%) were HIV services with their own coinfection clinics, 40 (42.1%) were HIV services that referred coinfected individuals to a local hepatology service and 20 (21.1%) were HIV services that referred to a regional specialist centre. Eighty‐one clinics provided full caseload estimates; of the approximately 3951 people with a history of HIV/HCV coinfection accessing their clinics, only 4.9% were believed to have detectable HCV RNA, 3.15% of whom were already receiving or approved for direct‐acting antiviral (DAA) treatment. In total, 29 (30.5%) of the clinics reported an impact of COVID‐19 on coinfection care, including delays or reductions in the frequency of services, monitoring, treatment initiation and appointments, and changes to the way that treatment was dispensed. Case‐note reviews were provided for 283 people with detectable HCV RNA from 74 clinics (median age 42 years, 74.6% male, 56.2% HCV genotype 1, 22.3% HCV genotype 3). Overall, 56% had not received treatment for HCV, primarily due to lack of engagement in care (54.7%) and/or being uncontactable (16.4%).Conclusions: Our findings show that the small number of people with HIV with detectable HCV RNA in the UK should mean that it is possible to achieve HCV micro‐elimination. However, more work is needed to improve engagement in care for those who are untreated for HCV.

19 July 2026 in Journal of Public Health Sciences
Verified
Journal Article
Open access
PDF file
RRReynie Purnama Raya
Reynie Purnama Raya
SHSanti Nur Holizah
Santi Nur Holizah
BIBhekti Imansari
Bhekti Imansari
The Triple Elimination Programme was first introduced in 2017 to standardise screening for pregnant women nationwide. Moving into 2025, however, coverage rates in several regions—including Bandung City—remain below national targets, pointing to an ongoing struggle with programme compliance. This study examined the association between knowledge, information sources, and family support with pregnant women’s compliance in the Triple Elimination programme. A cross-sectional study was conducted among 132 pregnant women attending health facilities in Arcamanik Sub-district, Bandung City. Participants were selected using purposive sampling, and data were collected using structured questionnaire. Univariate analyses described the frequency and distribution of variables, whilst bivariate analyses using Chi-squared and Mantel-Haenszel odds ratio (95% CI) assessed associations between knowledge, information sources, and family support with the pregnant women’s compliance. The results showed that most respondents had high knowledge (66.7%), adequate access to information (71.2%), and positive family support (67.4%), while 56.1% were compliant with the programme. Knowledge (OR [95% CI] = 10.99 [4.59–26.32], p<0.01), information sources (5.97 [2.57–13.87], p<0.01), and family support (15.66 [6.10–40.18], p<0.01) were all significantly associated with compliance, with family support being the strongest determinant. These findings highlight the importance of involving families in health education to strengthen pregnant women’s participation and improve the success of the Triple Elimination Programme.